Rhodes Jennifer J Insider Trades

Insider Trading History

Track insider trading activity for Rhodes Jennifer J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Evp, CHIEF LEGAL Officer, SEC
Holding Value $255k 11,280 shares
Last Trade
Mar 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$82.5k 3,844 shares
$21.47
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Evp, CHIEF LEGAL Officer, SEC
Holding Value $342k 15,124 shares
Last Trade
Mar 24, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 7,515 shares
$20.96
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Evp, CHIEF LEGAL Officer, SEC
Holding Value $510k 22,547 shares
Last Trade
Mar 24, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 7,515 shares
$20.96
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Evp, CHIEF LEGAL Officer, SEC
Holding Value $2.05M 90,691 shares
Last Trade
Mar 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.59M 117,073 shares
$22.16
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Evp, CHIEF LEGAL Officer, SEC
Holding Value $172k 7,609 shares
Last Trade
Feb 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$162k 6,950 shares
$23.38
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Evp, CHIEF LEGAL Officer, SEC
Holding Value $293k 12,945 shares
Last Trade
Feb 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$305k 12,944 shares
$23.56
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Evp, CHIEF LEGAL Officer, SEC
Holding Value $329k 14,559 shares
Last Trade
Feb 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$305k 12,944 shares
$23.56
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Evp, CHIEF LEGAL Officer, SEC
Holding Value $2.31M 102,289 shares
Last Trade
Mar 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.76M 102,289 shares
$17.23
$22.60
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Evp, CHIEF LEGAL Officer, SEC
Holding Value $2.86M 126,589 shares
Last Trade
Feb 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.26M 126,589 shares
$25.74
$22.60
Angion Biomedica
Angion Biomedica ANGN
See Remarks
Holding Value $275k 275,000 shares
Last Trade
Mar 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.7M 275,000 shares
$199.00
$1.00
Elicio Therapeutics
Elicio Therapeutics ELTX
Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer And Secretary
Holding Value $1.13M 275,000 shares
Last Trade
Mar 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.7M 275,000 shares
$199.00
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
Senior Vice President, General Counsel, Chief Compliance Officer And Corporate Secretary
Holding Value $125k 30,399 shares
Last Trade
Dec 14, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$106k 451 shares
$235.00
$4.11
Angion Biomedica
Angion Biomedica ANGN
See Remarks
Holding Value $30.4k 30,399 shares
Last Trade
Dec 14, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$106k 451 shares
$235.00
$1.00
Elicio Therapeutics
Elicio Therapeutics ELTX
Senior Vice President, General Counsel, Chief Compliance Officer And Corporate Secretary
Holding Value $127k 30,850 shares
Last Trade
Nov 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$182k 433 shares
$421.00
$4.11
Angion Biomedica
Angion Biomedica ANGN
See Remarks
Holding Value $30.9k 30,850 shares
Last Trade
Nov 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$182k 433 shares
$421.00
$1.00
Angion Biomedica
Angion Biomedica ANGN
See Remarks
Holding Value $31.3k 31,283 shares
Last Trade
Oct 14, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$373k 430 shares
$867.00
$1.00
Elicio Therapeutics
Elicio Therapeutics ELTX
Senior Vice President, General Counsel, Chief Compliance Officer And Corporate Secretary
Holding Value $129k 31,283 shares
Last Trade
Oct 14, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$373k 430 shares
$867.00
$4.11
Angion Biomedica
Angion Biomedica ANGN
See Remarks
Holding Value $31.7k 31,713 shares
Last Trade
Sep 14, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$459k 430 shares
$1,067.00
$1.00
Elicio Therapeutics
Elicio Therapeutics ELTX
Senior Vice President, General Counsel, Chief Compliance Officer And Corporate Secretary
Holding Value $130k 31,713 shares
Last Trade
Sep 14, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$459k 430 shares
$1,067.00
$4.11
Angion Biomedica
Angion Biomedica ANGN
See Remarks
Holding Value $32.1k 32,143 shares
Last Trade
Aug 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$460k 445 shares
$1,033.00
$1.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up